BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Agencies, delegations and associations at BIO‑Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

89 agencies, delegations and associations are at BIO-Europe 2026 — 44 presentations on the program. Most represented: European Medicines Agency (5 on the program), European Commission (4 on the program), EUCOPE (3 on the program). 70 of them have their own page in this guide. As of Nov 10, 2026.

All 473 organizations at BIO-Europe 2026 →

Track
Top represented
Showing 1–16 of 89 organizations
OrganizationBIO-Europe 2026 Attendance
European Medicines Agency
Amsterdam, Netherlands
Gov, delegations & associations
EU agency that evaluates and supervises medicines for human and veterinary use.
Panel
Mon Nov 9
11:15–12:00
Unlocking Pharma’s Productivity Potential
Why developing medicines keeps getting costlier and slower, and whether AI and research sourced from other companies can make drug companies more productive.
with Norstella, M Ventures, Blackstone Life Sciences +1 more
Business of Biotech
Panel
Tue Nov 10
13:00–13:45
Aligning with Regulators to Propel Innovation
What help and incentives the European Medicines Agency offers developers of new treatments, and how to use them on the road to approval.
with Federal Institute for Drugs and Medical Devices (BfArM), MSD
Panel
Tue Nov 10
14:00–14:45
Harnessing Regulatory Sandboxes to Drive Innovation in Novel Therapeutics & Technologies
How regulatory sandboxes, where regulators let new products be tested under adjusted rules, could support new therapies and health technologies in Europe.
with HTW Berlin, Innovative Health Initiative, CSL Behring
Panel
Wed Nov 11
10:00–10:45
AI Regulations: Driving Innovation While Navigating Compliance
What rules cover AI in drug development, where European and US regulators agree, and how rules could help rather than hinder innovation.
with Bayer
Panel
Wed Nov 11
09:00–09:45
From NAMs (New Approach Methodologies) Innovation to Regulatory acceptance: Accelerating human-relevant modelling
How lab models built on human biology, from organs-on-chips to AI computer models, can speed drug development and win regulators' acceptance.
with FRESCI, Merck KGaA, TissUse +2 more
European Commission
Brussels, Belgium
Gov, delegations & associations
Executive body of the European Union, proposing legislation and running EU programmes, including health, medicines and research policy.
Panel
Tue Nov 10
09:00–09:45
Accelerating Innovation and Market Exclusivity Through Regulatory Incentives
How updated EU drug laws and the Biotech Act change how long new medicines are shielded from competing copies, compared with rules elsewhere.
with Sanofi, Swedish Medical Products Agency, Novartis
Panel
Tue Nov 10
14:30–14:55
Investing in Women’s Health: How Can Europe Scale Innovation?
How Europe can grow investment in women's health, previewing a European Investment Bank study of the field's research, unmet needs and funding options.
with European Investment Bank
Panel
Wed Nov 11
09:00–09:45
From NAMs (New Approach Methodologies) Innovation to Regulatory acceptance: Accelerating human-relevant modelling
How lab models built on human biology, from organs-on-chips to AI computer models, can speed drug development and win regulators' acceptance.
with FRESCI, Merck KGaA, TissUse +2 more
EUCOPE
Brussels, Belgium
Gov, delegations & associations
Trade association representing small and mid-sized innovative pharmaceutical and biotech companies in Europe.
Panel
Tue Nov 10
10:30–10:55
Addressing Unmet Medical Needs in Europe’s Evolving Pharmaceutical Landscape
How regulators judge which diseases lack good treatments, which faster approval routes apply, and whether recent EU drug law changes have helped.
with PTC Therapeutics
Panel
Wed Nov 11
12:00–12:45
HTA Regulation: Early Insights and Reimbursement Implications
Early lessons from the EU's new joint reviews of how much new drugs help patients, and whether they ease or hinder patient access.
with Lundbeck
Panel
Wed Nov 11
10:00–10:45
Most Favoured Nations: A Game-Changer for Biotech Dealmaker?
How the US 'most favoured nation' policy, which ties US drug prices to prices paid abroad, is changing drug deals and European launch plans.
with Bristol Myers Squibb, Boehringer Ingelheim
Biotechnology Innovation Organization (BIO)
Washington, District of Columbia
Gov, delegations & associations
Trade association representing biotechnology companies, and organizer of the BIO International Convention.
Keynote
Mon Nov 9
10:15–10:30
Opening Remarks
The Big Picture Plenary Series · with Informa, Ministry of Economic Affairs, Industry, Climate Action and Energy of North Rhine-Westphalia
Panel
Wed Nov 11
09:30–09:55
The State of Biopharma Deal-Making in 2026: Global Trends & Strategic Shifts
What the numbers show about this year's drug licensing deals and acquisitions, cross-border partnerships, and the disease areas buyers favor.
Government of Canada
Ottawa, Canada
○Supporter
Gov, delegations & associationsDelegation or supporter
Canada's federal government, represented through its Trade Commissioner Service, which helps Canadian companies do business abroad.
Panel
Mon Nov 9
14:00–14:25
Get in the Mix with Canada’s Picks: Innovation in Life Sciences
Selected Canadian companies present their health technologies, alongside an overview of Canada's life sciences sector and its partnership opportunities.
with Government of Ontario, Life Sciences BC, GenAIz +3 more
Life Science Nord
Hamburg, Germany
○Supporter
Gov, delegations & associationsDelegation or supporter
Life sciences industry cluster for Hamburg and Schleswig-Holstein in northern Germany.
Panel
Mon Nov 9
14:00–14:45
Community Conversations – Session 1
Attendees join small-group lunch tables on a topic of their choice, from regulatory strategy and global launches to hiring talent and managing partnerships.
with R Kupiec Consulting, Graythan Regulatory Services, Sartorius +3 more
Business of BiotechRegulatory Strategy
Panel
Mon Nov 9
15:00–15:45
Community Conversations – Session 2
A second round of the same small-group lunch tables, letting attendees switch to another topic such as regulatory strategy, launches or partnerships.
with R Kupiec Consulting, Graythan Regulatory Services, Sartorius +3 more
Business of BiotechRegulatory Strategy
One Nucleus
Cambridge, United Kingdom
○Supporter
Gov, delegations & associationsDelegation or supporter
Membership organization for life sciences and healthcare companies in Cambridge, London and the wider UK.
Panel
Mon Nov 9
14:00–14:45
Community Conversations – Session 1
Attendees join small-group lunch tables on a topic of their choice, from regulatory strategy and global launches to hiring talent and managing partnerships.
with R Kupiec Consulting, Graythan Regulatory Services, Sartorius +3 more
Business of BiotechRegulatory Strategy
Panel
Mon Nov 9
15:00–15:45
Community Conversations – Session 2
A second round of the same small-group lunch tables, letting attendees switch to another topic such as regulatory strategy, launches or partnerships.
with R Kupiec Consulting, Graythan Regulatory Services, Sartorius +3 more
Business of BiotechRegulatory Strategy
Gov, delegations & associations
EU programme funding breakthrough technologies and startups through grants and equity investments.
Panel
Mon Nov 9
16:00–16:45
Fuelling Innovation: The State of Early-Stage Investment in Biotech
Investors and founders discuss how young biotech startups raise early funding today and how venture investors' priorities are shifting.
with Eir Ventures, High-Tech Gründerfonds, Earlybird Venture Capital +2 more
Panel
Wed Nov 11
09:00–09:45
From NAMs (New Approach Methodologies) Innovation to Regulatory acceptance: Accelerating human-relevant modelling
How lab models built on human biology, from organs-on-chips to AI computer models, can speed drug development and win regulators' acceptance.
with FRESCI, Merck KGaA, TissUse +2 more
○Supporter
Gov, delegations & associationsDelegation or supporter
Network organization for the biotech sector in Munich and Bavaria, supporting startups and companies.
Panel
Mon Nov 9
16:00–16:45
Cell and Gene Therapy: What Should You Know?
Where gene therapies stand across diseases, and what shifting funding and partnerships mean for regulation, manufacturing, investment and market access.
with Sofinnova Partners, VeonGen Therapeutics
◆Platinum Sponsor
Gov, delegations & associationsPlatinum sponsor
Health innovation cluster of Wallonia, Belgium, connecting biotech and medtech companies, universities and research centres.
Talk
Wed Nov 11
10:30–11:00
From Innovation to Scalable Manufacturing: Closing the Gap
Biotechs, researchers and contract manufacturers discuss what it takes to scale a new therapy into a product made reliably under strict quality rules.
with Superbranche, Cellistic, Fraunhofer IZI
Germany Trade & Invest
Berlin, Germany
◆Gold Sponsor · HEALTH MADE IN GERMANY
Gov, delegations & associationsGold sponsor
Germany's economic development agency promoting the country as a business location; Health Made in Germany is its healthcare industry initiative.
Panel
Tue Nov 10
09:30–09:55
Biopharma Ecosystem Germany: Spotlight on Innovation Drivers Ready for Take-Off
Five teams from Germany's biotech scene, which spans university research, companies, drug manufacturing and healthcare, show their work and its impact.
with Rentschler Biopharma, FGK Clinical Research, CD4 Therapeutics +1 more
Government of Ontario
Toronto, Canada
○Supporter
Gov, delegations & associationsDelegation or supporter
Provincial government of Ontario, Canada, promoting Ontario companies to international buyers and partners.
Panel
Mon Nov 9
14:00–14:25
Get in the Mix with Canada’s Picks: Innovation in Life Sciences
Selected Canadian companies present their health technologies, alongside an overview of Canada's life sciences sector and its partnership opportunities.
with Government of Canada, Life Sciences BC, GenAIz +3 more
JETRO
Tokyo, Japan
◆Platinum Sponsor
Gov, delegations & associationsPlatinum sponsor
Japan External Trade Organization, the government agency promoting trade and investment between Japan and other countries.
Talk
Tue Nov 10
10:45–11:00
Unlocking Japan: Opportunities for Global Biotech to Access and Navigate the Japanese Market
How foreign biotechs can get government-backed help finding partners and investors in Japan, and what its two major biotech regions offer.
with METI Kansai, National Cancer Center Japan
Life Sciences BC
Vancouver, Canada
○Supporter
Gov, delegations & associationsDelegation or supporter
Industry association representing the life sciences sector in British Columbia, Canada.
Panel
Mon Nov 9
14:00–14:25
Get in the Mix with Canada’s Picks: Innovation in Life Sciences
Selected Canadian companies present their health technologies, alongside an overview of Canada's life sciences sector and its partnership opportunities.
with Government of Canada, Government of Ontario, GenAIz +3 more
SPRIND
Leipzig, Germany
◆Gold Sponsor
Gov, delegations & associationsGold sponsor
Germany's Federal Agency for Breakthrough Innovation, funding and building ventures around high-risk, high-impact technologies.
Panel
Mon Nov 9
15:00–15:25
Unpacking the deal
Business of Biotech · with EQT Life Sciences, Tubulis
B
BackingHerVenture
Gov, delegations & associations
German non-profit association supporting women founders in healthcare and life sciences through leadership programs and networks.
Panel
Tue Nov 10
13:00–13:45
Building Biotech Companies, Not Just Funding Them
How investors now build biotechs from scratch around university science, supplying leaders and shared resources, and whether that can be made repeatable.
with Pioneer Group, ALTx Therapeutics, BioInnovation Institute +1 more

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from agencies, delegations and associations

Tell us what you sell and we’ll find the people at these agencies, delegations and associations most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse BIO-Europe 2026 by

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction